background: Cardiogenic shock (CSh) is a state of low cardiac output that results in hypoperfusion and hypoxia in end organs.The most common cause is myocardial infarction (AMI) with left ventricular dysfunction.Before the routine use of early revascularization, CSh associated with AMI had an in-hospital mortality that exceeded 80%, however, since the start of therapy, this figure has decreased, however it remains a high percentage of mortality (27-51%).Objective: To review new concepts on cardiogenic shock, etiologies and current management to be reproduced in medical practice.Conclusion: The early recognition of the different hemodynamic patterns that occur according to the etiology of the CSh, are highly related to the specific treatment of this, considering the different mechanisms of vasoactive drugs that would improve not only the prognosis of the patients, but also survival.Not without leaving behind invasive mechanical assist devices such as heart transplantation.